RimAsia Capital Partners, L.P.'s Net Worth

$76.3 Million

Estimate Recalculated Sep 8, 2024 07:26PM EST

Who is RimAsia Capital Partners, L.P.?

RimAsia Capital Partners, L.P. has an estimated net worth of $76.3 Million. This is based on reported shares across multiple companies, which include NeoStem, Inc., and CHINA BIOPHARMACEUTICALS HOLDINGS INC.

SEC CIK

RimAsia Capital Partners, L.P.'s CIK is 0001369127

Past Insider Trading and Trends

2009 was RimAsia Capital Partners, L.P.'s most active year for acquiring shares with 5 total transactions. RimAsia Capital Partners, L.P.'s most active month to acquire stocks was the month of September. 2010 was RimAsia Capital Partners, L.P.'s most active year for disposing of shares, totalling 2 transactions. RimAsia Capital Partners, L.P.'s most active month to dispose stocks was the month of February. 2010 saw RimAsia Capital Partners, L.P. paying a total of $10,927,511.95 for 10,951,865 shares, this is the most they've acquired in one year. In 2014 RimAsia Capital Partners, L.P. cashed out on 13,940 shares for a total of $49,204.02, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

NeoStem, Inc. (LSTA) Snapshot price: $3.13

Investor

RimAsia Capital Partners, L.P. owns 12,323,750 units of Common Stock which is worth $38,573,337.50, 13,323,750 units of Common Stock par value $0.001 per share which is worth $41,703,337.50 and 2,210,988 units of Common Stock, par value $0.001 per share which is worth $6,920,392.44. In the year 2008 RimAsia Capital Partners, L.P. acquired a total of 21,665,180 shares in NeoStem, Inc. at a cost of $10,927,511.95, RimAsia also disposed a total of 13,940 shares of NeoStem, Inc. equalling to $49,204.02.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+0.54%
12K
—
—
2.22M
Jan 2
Form 4
-0.63%
-13.94K
$3.53
-$49,204.02
2.21M
Dec 9
Form 4
-0.72%
-16.06K
$3.75
-$60,225.00
2.22M
Dec 8
Form 4
-0.53%
-12.00K
$4.01
-$48,170.27
2.24M
Dec 2 - Dec 3
Form 4
+0.54%
12K
—
—
2.25M
Jan 2
Form 4
-0.56%
-12.53K
$6.37
-$79,807.42
2.24M
Dec 6 - Dec 9
Form 4
-0.44%
-10.00K
$6.26
-$62,620.00
2.25M
Nov 26
Form 4
+0.53%
120K
—
—
22.67M
Jan 4
Form 4
+0.07%
15.31K
—
—
22.55M
Jul 20
Form 4
+0.54%
120K
—
—
22.53M
Jan 12
Form 4
+68.19%
9.09M
$0.90
$8,177,511.60
22.41M
May 17
Form 4
+8.11%
1M
$1.75
$1,750,000.00
13.32M
Mar 15
Form 4
+7.56%
865.74K
$1.35
$1,000,000.35
12.32M
Feb 18
Form 4
+1,045.80%
10.46M
—
—
11.46M
Oct 30
Form 4
—
0
—
—
0
Apr 9
Form 3
—
0
—
—
0
No matching records found

CHINA BIOPHARMACEUTICALS HOLDINGS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found